Gefitinib toxicity has been significantly correlated with survival in non-small cell lung cancer patients treated in EAP program in Czech Republic

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ZEMANOVÁ Milada PETRUZELKA Luboš ZATLOUKAL Petr PEŠEK Miloš GRYGÁROVÁ Ivona SKŘIČKOVÁ Jana SVOBODNÍK Adam VRÁNA David

Year of publication 2007
Type Article in Proceedings
Conference Journal of Thoracic Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords Gefitinib; toxicity; non-small cell lung cancer;survival
Description Toxicity of the anti-tumour drug, Gefitinib, has been followed up in a multi-center study of non-small cell lung cancer and correlated with patients' survival. The results in the Czech leg of the study have suggested a significant correlation.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.